Image

Blood Flow Restriction and Transcutaneous Electrical Nerve Stimulation on Motor Function in Stroke

Blood Flow Restriction and Transcutaneous Electrical Nerve Stimulation on Motor Function in Stroke

Recruiting
50-80 years
All
Phase N/A

Powered by AI

Overview

Stroke commonly results in persistent leg impairments that limit mobility and reduce quality of life. This study investigates whether combining low-intensity resistance training with blood flow restriction (LIRT-BFR) and transcutaneous electrical nerve stimulation (TENS) can effectively improve leg function in stroke survivors.

Participants with chronic stroke will be randomly assigned to one of four intervention groups: 1) LIRT with simulated BFR and simulated TENS; 2) LIRT with actual BFR and simulated TENS; 3) LIRT with simulated BFR and actual TENS; 4) LIRT with both actual BFR and actual TENS. The resistance training utilizes 20% of each participant's maximum lifting capacity. For blood flow restriction, an automated pressure cuff (SmartCuffs 4.0) will be placed on the upper portion of the affected leg, inflated to 50% of the individual's occlusion pressure during exercises and deflated during rest periods. TENS therapy delivers controlled electrical impulses through electrodes positioned on the anterior thigh.

Each 60-minute session includes a 10-minute warm-up followed by 40 minutes of targeted resistance exercises (leg extensions, leg presses, and weight-bearing squats) and concludes with 10 minutes of stationary cycling. The resistance protocol involves 3 sets of 20 repetitions with standardized rest intervals between sets and exercises. Participants will attend three sessions weekly for six weeks.

Assessments will be conducted at baseline, midpoint (3 weeks), completion (6 weeks), and follow-up (1 month post-intervention). The primary outcome measure is the Fugl-Meyer Assessment for Lower Extremity function, with secondary measures including muscle strength, stiffness, balance, mobility, walking capacity, and gait parameters. To understand the underlying mechanisms, we will measure muscle oxygenation using near-infrared spectroscopy, evaluate muscle structure via ultrasound, and monitor physiological responses including heart rate variability and perceived exertion for safety monitoring.

Description

Stroke often leads to persistent lower-limb impairments, limiting functional recovery and quality of life. Low-intensity resistance training with blood flow restriction (LIRT-BFR) has shown promise in improving muscle function in healthy populations, but its effects in stroke rehabilitation remain underexplored. Additionally, while BFR and electrical stimulation have been beneficial for pain relief and muscle activation, the impact of combining BFR with transcutaneous electrical nerve stimulation (TENS) in stroke patients remains unknown. The objectives of this study is to evaluate whether a multi-mode exercise rehabilitation training program of LIRT-BFR and TENS can restore lower extremity strength, mobility, and quality of life.

In this randomized controlled trial, chronic stroke patients will be allocated to one of four groups: 1) LIRT + sham BFR + sham TENS, 2) LIRT + BFR + sham TENS, 3) LIRT + sham BFR + TENS, and 4) LIRT + BFR + TENS. The LIRT protocol utilizes 20% of one-repetition maximum (1-RM) as the standardized training load. BFR implementation involves an automated restriction band (SmartCuffs 4.0) positioned at the proximal region of the affected lower extremity, calibrated to 50% of the individual's lower limb occlusion pressure (LOP). The pressure system remains inflated throughout active training phases and is systematically deflated during inter-exercise intervals. TENS application targets the anterior thigh region.

The intervention protocol comprises a structured 60-minute session beginning with a 10-minute preparatory warm-up, followed by 40 minutes of targeted resistance exercises including leg extensions, leg presses, and load-bearing squats focused on the affected limb, concluding with 10 minutes of aerobic cycling. Each resistance exercise consists of 3 sets of 20 repetitions with rest intervals. The assessments will be conducted at baseline, mid-intervention (3 weeks), post-intervention (6 weeks), and follow-up (1 month post-completion).

The primary outcome measure will be the Fugl-Meyer Assessment Lower Extremity (FMA-LE) score, and secondary outcome measures including muscle strength, stiffness, balance, functional mobility, walking capacity, gait speed, etc. To elucidate the underlying mechanisms, the study will use near-infrared spectroscopy (NIRS) to assess muscle oxygenation and hemodynamics, ultrasound for muscle morphology, and exercise measures like heart rate variability (HRV) and rating of perceived exertion (RPE) for safety consideration.

Eligibility

Inclusion Criteria:

  1. are between 50 and 80 years of age;
  2. have had a single stroke more than 6 months and less than 15 years;
  3. have at least 5 degrees of active ankle dorsiflexion in the antigravity position;
  4. are able to walk 10 m independently, with or without a walking aid;
  5. are able to score 6 or higher out of 10 on the abbreviated mental test;
  6. have no skin allergies (e.g. redness or itchiness after application of the electrical stimulation pads) to electrical stimulation or electrodes;
  7. are able to follow instructions and give informed consent.

Exclusion Criteria:

  1. presence of other comorbidities like varicose veins, peripheral neuropathy, cancer, musculoskeletal injury, lower limb peripheral edema, post-surgical swelling, open wounds, or on a medication that increases blood clotting risk;
  2. resting blood pressure ≥ 160/100 mmHg even after taking medications, cardiovascular comorbidity, heart failure, unstable angina, by-pass surgery, a pacemaker;
  3. administration of botulinum toxin in the lower limb at least 6 months prior to training;
  4. history of epilepsy, cochlear implants, any type of deep brain stimulator and metal implants in the head or neck;
  5. currently not participating in resistance training or high-intensity or long duration cardiovascular exercise;
  6. lack the ability to feel pain (because of paralysis), or other subjects who cannot complain of discomfort.

Study details
    Chronic Stroke

NCT06973590

The Hong Kong Polytechnic University

15 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.